CAPTRUST Financial Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.77M Buy
15,609
+3,767
+32% +$428K ﹤0.01% 1031
2025
Q1
$1.25M Sell
11,842
-192
-2% -$20.2K ﹤0.01% 1148
2024
Q4
$1.29M Sell
12,034
-188
-2% -$20.1K ﹤0.01% 1099
2024
Q3
$1.22M Sell
12,222
-407
-3% -$40.7K ﹤0.01% 1072
2024
Q2
$1.06M Buy
12,629
+5,912
+88% +$498K ﹤0.01% 1103
2024
Q1
$491K Buy
6,717
+402
+6% +$29.4K ﹤0.01% 1491
2023
Q4
$451K Buy
6,315
+330
+6% +$23.6K ﹤0.01% 1805
2023
Q3
$359K Buy
+5,985
New +$359K ﹤0.01% 1882
2022
Q3
Sell
-1,446
Closed -$80K 3164
2022
Q2
$80K Buy
1,446
+16
+1% +$885 ﹤0.01% 2376
2022
Q1
$100K Sell
1,430
-713
-33% -$49.9K ﹤0.01% 2264
2021
Q4
$207K Sell
2,143
-276
-11% -$26.7K ﹤0.01% 1614
2021
Q3
$210K Buy
2,419
+56
+2% +$4.86K ﹤0.01% 1527
2021
Q2
$193K Sell
2,363
-1
-0% -$82 ﹤0.01% 1548
2021
Q1
$225K Buy
2,364
+2,175
+1,151% +$207K ﹤0.01% 1390
2020
Q4
$12K Buy
189
+8
+4% +$508 ﹤0.01% 2484
2020
Q3
$11K Sell
181
-754
-81% -$45.8K ﹤0.01% 2243
2020
Q2
$65K Sell
935
-1,681
-64% -$117K ﹤0.01% 1520
2020
Q1
$111K Buy
+2,616
New +$111K ﹤0.01% 1078
2019
Q4
Sell
-596
Closed -$37K 1452
2019
Q3
$37K Hold
596
﹤0.01% 1093
2019
Q2
$42K Buy
596
+64
+12% +$4.51K ﹤0.01% 1036
2019
Q1
$42K Buy
532
+399
+300% +$31.5K ﹤0.01% 959
2018
Q4
$11K Hold
133
﹤0.01% 1204
2018
Q3
$23K Buy
133
+128
+2,560% +$22.1K ﹤0.01% 957
2018
Q2
$1K Sell
5
-9
-64% -$1.8K ﹤0.01% 1457
2018
Q1
$1K Buy
+14
New +$1K ﹤0.01% 1281